Efficacy and safety of SGLT-2 inhibitors in patients with comorbid type 2 diabetes and atrial fibrillation: A meta-analysis
{{output}}
This meta-analysis investigated the efficacy and safety of sodium-glucose cotransporter-2 inhibitors (SGLT-2i) in patients with type 2 diabetes mellitus (T2DM) and atrial fibrillation (AF), a topic with limited prior consensus. A systematic search of six elect... ...
